< Back to previous page
Researcher
Ignace Vergote
- Disciplines:Gynaecology and obstetrics, Nursing, Endocrinology and metabolic diseases
Affiliations
- Gynaecological Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 10 of 12
- Exploring the heterogeneity of rare ovarian cancerDefining (epi)genomic transition from precursor lesion to invasive rare ovarian cancerFrom1 Apr 2020 → 1 Apr 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Predictive genetic markers for targeted therapy in gynaecological malignancies: bridging the gap between “one-size-fits-all” and more personalised treatment approach.From1 Aug 2019 → 11 Oct 2023Funding: FWO Strategic Basic Research Grant
- Comprehensive genomic and transcriptomic analysis of high grade serous ovarian cancer using single-cell RNA-sequencing.From1 Jan 2019 → 31 Dec 2021Funding: Foundations, funds and other with scientific goal
- Searching for new leads in the diagnosis of ovarian cancerFrom1 Oct 2017 → 30 Sep 2021Funding: Foundations, funds and other with scientific goal
- Comprehensive transcriptomic analysis of high-grade serous tubo-ovarian carcinoma using single-cell RNA-sequencing.From1 Mar 2017 → 5 Jul 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- From Never to Always Events: in search for mango-momentsFrom1 Nov 2016 → 31 Oct 2018Funding: Nonprofit institution or equivalents
- FIRST PET-MR: Flmeish interuniversity research simultaneous time-of-flight PET-MR scanner.From14 Aug 2014 → 13 Feb 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Flemish interuniversity simultaneous time-of-flight PET-MR scanner for research.From14 Aug 2014 → 13 Feb 2019Funding: Hercules - Large scale research infrastructure
- A drug strategy targeting stabilised mutant p53 to fight metastatic plantinum-resistant ovarian cancer.From1 Oct 2013 → 31 Mar 2019Funding: General Activities (Annex IV)
- Dendritic cell immunotherapy in serous ovarian cancer.From1 Oct 2013 → 30 Sep 2016Funding: FWO fellowships
Publications
31 - 40 of 773
- Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance(2023)
Authors: Ignace Vergote
- Safety analysis of lurbinectedin versus topotecan in elderly patients(2023)
Authors: Ignace Vergote
- Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort study(2023)
Authors: Eva Oldenburger, Albert Wolthuis, Els Van Nieuwenhuysen, Patrick Neven, Ignace Vergote, Sileny Han
Pages: 1539 - 1545 - INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line(2023)
Authors: Ignace Vergote
Pages: 1503 - 1513 - Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study(2023)
Authors: Ignace Vergote
Pages: 562 - 570 - Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?(2023)
Authors: Ignace Vergote, Toon Van Gorp
Pages: 201 - 211 - CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study(2023)
Authors: Diether Lambrechts, Liselore Loverix, Toon Van Gorp, Els Van Nieuwenhuysen, Ignace Vergote
Pages: 697 - 713 - Systematic study of tissue factor expression in solid tumors(2023)
Authors: Siel Olbrecht, Ignace Vergote
- Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment(2023)
Authors: Ignace Vergote
- Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort(2023)
Authors: Tom Bourne, Wouter Froyman, Ben Van Calster, Jolien Ceusters, Laure Wynants, An Coosemans, Ignace Vergote, Dirk Timmerman
Pages: 231 - 242
Patents
1 - 1 of 1
- Methods for diagnosing ovarian cancer (Inventor)